394 related articles for article (PubMed ID: 28815559)
1. Characteristic elevation of soluble TNF receptor II : I ratio in macrophage activation syndrome with systemic juvenile idiopathic arthritis.
Shimizu M; Inoue N; Mizuta M; Nakagishi Y; Yachie A
Clin Exp Immunol; 2018 Mar; 191(3):349-355. PubMed ID: 28815559
[TBL] [Abstract][Full Text] [Related]
2. Soluble CD163, a unique biomarker to evaluate the disease activity, exhibits macrophage activation in systemic juvenile idiopathic arthritis.
Sakumura N; Shimizu M; Mizuta M; Inoue N; Nakagishi Y; Yachie A
Cytokine; 2018 Oct; 110():459-465. PubMed ID: 29801971
[TBL] [Abstract][Full Text] [Related]
3. Comparison of serum biomarkers for the diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis during tocilizumab therapy.
Irabu H; Shimizu M; Kaneko S; Inoue N; Mizuta M; Nakagishi Y; Yachie A
Pediatr Res; 2020 Dec; 88(6):934-939. PubMed ID: 32184444
[TBL] [Abstract][Full Text] [Related]
4. Comparison of serum cytokine profiles in macrophage activation syndrome complicating different background rheumatic diseases in children.
Mizuta M; Shimizu M; Irabu H; Usami M; Inoue N; Nakagishi Y; Wada T; Yachie A
Rheumatology (Oxford); 2021 Jan; 60(1):231-238. PubMed ID: 32681176
[TBL] [Abstract][Full Text] [Related]
5. Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-γ.
Put K; Avau A; Brisse E; Mitera T; Put S; Proost P; Bader-Meunier B; Westhovens R; Van den Eynde BJ; Orabona C; Fallarino F; De Somer L; Tousseyn T; Quartier P; Wouters C; Matthys P
Rheumatology (Oxford); 2015 Aug; 54(8):1507-17. PubMed ID: 25767156
[TBL] [Abstract][Full Text] [Related]
6. Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
Davì S; Minoia F; Pistorio A; Horne A; Consolaro A; Rosina S; Bovis F; Cimaz R; Gamir ML; Ilowite NT; Kone-Paut I; Feitosa de Oliveira SK; McCurdy D; Silva CA; Sztajnbok F; Tsitsami E; Unsal E; Weiss JE; Wulffraat N; Abinun M; Aggarwal A; Apaz MT; Astigarraga I; Corona F; Cuttica R; D'Angelo G; Eisenstein EM; Hashad S; Lepore L; Mulaosmanovic V; Nielsen S; Prahalad S; Rigante D; Stanevicha V; Sterba G; Susic G; Takei S; Trauzeddel R; Zletni M; Ruperto N; Martini A; Cron RQ; Ravelli A;
Arthritis Rheumatol; 2014 Oct; 66(10):2871-80. PubMed ID: 25044674
[TBL] [Abstract][Full Text] [Related]
7. Disruption of vascular endothelial homeostasis in systemic juvenile idiopathic arthritis-associated macrophage activation syndrome: The dynamic roles of angiopoietin-1 and -2.
Tasaki Y; Shimizu M; Inoue N; Mizuta M; Nakagishi Y; Wada T; Yachie A
Cytokine; 2016 Apr; 80():1-6. PubMed ID: 26908294
[TBL] [Abstract][Full Text] [Related]
8. Clinical Significance of Serum Soluble TNF Receptor I/II Ratio for the Differential Diagnosis of Tumor Necrosis Factor Receptor-Associated Periodic Syndrome From Other Autoinflammatory Diseases.
Yasumura J; Shimizu M; Toma T; Yashiro M; Yachie A; Okada S
Front Immunol; 2020; 11():576152. PubMed ID: 33162992
[No Abstract] [Full Text] [Related]
9. The role of interleukin-18 in the diagnosis and monitoring of hemophagocytic lymphohistiocytosis/macrophage activation syndrome - a systematic review.
Krei JM; Møller HJ; Larsen JB
Clin Exp Immunol; 2021 Feb; 203(2):174-182. PubMed ID: 33128796
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of Interleukin-18 as a Diagnostic Biomarker to Differentiate Adult-Onset Still's Disease With/Without Macrophage Activation Syndrome From Other Secondary Hemophagocytic Lymphohistiocytosis in Adults.
Shiga T; Nozaki Y; Tomita D; Kishimoto K; Hirooka Y; Kinoshita K; Funauchi M; Matsumura I
Front Immunol; 2021; 12():750114. PubMed ID: 34691064
[TBL] [Abstract][Full Text] [Related]
11. Systemic onset juvenile idiopathic arthritis with macrophage activation syndrome and coronary artery dilatation misdiagnosed as Kawasaki disease.
Keskindemirci G; Aktay Ayaz N; Melikoğlu N; Bornaun H; Aydoğmuş Ç; Aldemir E; Aydoğan G
Turk J Pediatr; 2015; 57(5):518-21. PubMed ID: 27411422
[TBL] [Abstract][Full Text] [Related]
12. An unusual presentation of purine nucleoside phosphorylase deficiency mimicking systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome.
Arduini A; Marasco E; Marucci G; Pardeo M; Insalaco A; Caiello I; Moneta GM; Prencipe G; De Benedetti F; Bracaglia C
Pediatr Rheumatol Online J; 2019 May; 17(1):25. PubMed ID: 31118063
[TBL] [Abstract][Full Text] [Related]
13. Paediatric rheumatic disease: Diagnosing macrophage activation syndrome in systemic JIA.
Vastert SJ; Prakken BJ
Nat Rev Rheumatol; 2014 Nov; 10(11):640-2. PubMed ID: 25201384
[TBL] [Abstract][Full Text] [Related]
14. Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis.
Shimizu M; Yokoyama T; Yamada K; Kaneda H; Wada H; Wada T; Toma T; Ohta K; Kasahara Y; Yachie A
Rheumatology (Oxford); 2010 Sep; 49(9):1645-53. PubMed ID: 20472718
[TBL] [Abstract][Full Text] [Related]
15. Complications of complications: diagnosis and treatment of recurrent macrophage activation syndrome in a patient with well-controlled systemic juvenile idiopathic arthritis.
Macaraeg M; Schulert GS
RMD Open; 2023 Jan; 9(1):. PubMed ID: 36690384
[TBL] [Abstract][Full Text] [Related]
16. Differentiating macrophage activation syndrome in systemic juvenile idiopathic arthritis from other forms of hemophagocytic lymphohistiocytosis.
Lehmberg K; Pink I; Eulenburg C; Beutel K; Maul-Pavicic A; Janka G
J Pediatr; 2013 Jun; 162(6):1245-51. PubMed ID: 23333131
[TBL] [Abstract][Full Text] [Related]
17. Adenosine deaminase 2 as a biomarker of macrophage activation syndrome in systemic juvenile idiopathic arthritis.
Lee PY; Schulert GS; Canna SW; Huang Y; Sundel J; Li Y; Hoyt KJ; Blaustein RB; Wactor A; Do T; Halyabar O; Chang MH; Dedeoglu F; Case SM; Meidan E; Lo MS; Sundel RP; Richardson ET; Newburger JW; Hershfield MS; Son MB; Henderson LA; Nigrovic PA
Ann Rheum Dis; 2020 Feb; 79(2):225-231. PubMed ID: 31707357
[TBL] [Abstract][Full Text] [Related]
18. Elevated circulating levels of interferon-γ and interferon-γ-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
Bracaglia C; de Graaf K; Pires Marafon D; Guilhot F; Ferlin W; Prencipe G; Caiello I; Davì S; Schulert G; Ravelli A; Grom AA; de Min C; De Benedetti F
Ann Rheum Dis; 2017 Jan; 76(1):166-172. PubMed ID: 27296321
[TBL] [Abstract][Full Text] [Related]
19. Specific cytokine patterns in Epstein-Barr virusassociated hemophagocytic lymphohistiocytosis compared to Kawasaki disease in children.
Yang Y; Yu H; Li C; Gui Z; Chang Y
Pediatr Hematol Oncol; 2023; 40(6):529-538. PubMed ID: 37178062
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-18 for predicting the development of macrophage activation syndrome in systemic juvenile idiopathic arthritis.
Shimizu M; Nakagishi Y; Inoue N; Mizuta M; Ko G; Saikawa Y; Kubota T; Yamasaki Y; Takei S; Yachie A
Clin Immunol; 2015 Oct; 160(2):277-81. PubMed ID: 26101092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
